Scarica l'app Stockscreener
4.64
2.48%
-0.1182
Dopo l'orario di chiusura:
5.00
0.36
+7.76%
Precedente Chiudi:
$4.7582
Aprire:
$4.62
Volume 24 ore:
29,142
Relative Volume:
2.42
Capitalizzazione di mercato:
$16.95M
Reddito:
$11.68M
Utile/perdita netta:
$-8.85M
Rapporto P/E:
-1.9253
EPS:
-2.41
Flusso di cassa netto:
$-14.61M
1 W Prestazione:
-3.13%
1M Prestazione:
-8.84%
6M Prestazione:
-15.87%
1 anno Prestazione:
+117.83%
Intervallo 1D:
$4.58
$4.8433
Intervallo di 1 settimana:
$4.58
$5.00
Portata 52W:
$1.96
$10.40
Pulmatrix Inc Stock (PULM) Company Profile
Nome
Pulmatrix Inc
Settore
Industria
Telefono
(888) 355-4440
Indirizzo
945 CONCORD STREET, FRAMINGHAM, MA
Confronta PULM con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PULM
Pulmatrix Inc
|
4.64 | 17.90M | 11.68M | -8.85M | -14.61M | -2.41 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.61 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.07 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
569.17 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
837.28 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
318.02 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Pulmatrix Inc Stock (PULM) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2018-02-09 | Iniziato | H.C. Wainwright | Buy |
Pulmatrix Inc Borsa (PULM) Ultime notizie
Evaluating Pulmatrix Inc. with trendline analysisMarket Risk Summary & Weekly High Potential Stock Alerts - newser.com
Pulmatrix Swaps Drug Trials For Merger Plans With Cullgen - Finimize
Pulmatrix, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener
PULM: Pulmatrix Nears Potential Merger with Cullgen - GuruFocus
Pulmatrix : Quarterly Report for Quarter Ending September 30, 2025 (Form 10-Q) - MarketScreener
Pulmatrix, Inc. SEC 10-Q Report - TradingView
Biopharma Pulmatrix's Q3 revenue drops to $0 as trial ends, plans asset divestment - MarketScreener
Pulmatrix Announces Third Quarter 2025 Financial Results and Divestment Plan for Migraine and Inhalation Assets - PR Newswire
Is Pulmatrix Inc. stock gaining market shareWeekly Profit Analysis & Free Daily Entry Point Trade Alerts - newser.com
Can Pulmatrix Inc. hit a new high this monthInflation Watch & Free Expert Verified Stock Movement Alerts - newser.com
Is Pulmatrix Inc. stock a bargain at current levels2025 Risk Factors & AI Forecasted Entry and Exit Points - newser.com
Risk adjusted return profile for Pulmatrix Inc. analyzedPortfolio Value Report & Stepwise Trade Execution Plans - newser.com
Will Pulmatrix Inc. stock deliver consistent dividendsWeekly Trade Analysis & Low Drawdown Momentum Ideas - newser.com
Applying Wyckoff theory to Pulmatrix Inc. stock2025 Stock Rankings & Safe Entry Trade Reports - newser.com
Best data tools to analyze Pulmatrix Inc. stock2025 Market Sentiment & Fast Moving Stock Trade Plans - newser.com
What analysts say about Pulmatrix Inc stockRetail Investor Activity & Free Daily Top Stock Picks for All Investors - earlytimes.in
Using data tools to time your Pulmatrix Inc. exitM&A Rumor & Community Trade Idea Sharing Platform - newser.com
Heatmap analysis for Pulmatrix Inc. and competitorsJuly 2025 Intraday Action & Daily Volume Surge Trade Alerts - newser.com
Using Python tools to backtest Pulmatrix Inc. strategiesTrade Performance Summary & AI Optimized Trade Strategies - newser.com
Can Pulmatrix Inc. (2PU) stock withstand sector downturnsSell Signal & Free Safe Entry Trade Signal Reports - newser.com
Will Rising Interest Rates Hurt Super Crop Safe Limiteds Profit MarginsRisk-Reward Ratio Analysis & Breakout Portfolio Performance - earlytimes.in
What drives Pulmatrix Inc 2PU stock priceTechnology Stock Trends & Free Stock Index Interpretations - earlytimes.in
Can a trend reversal in Pulmatrix Inc. lead to recoveryPortfolio Value Summary & Weekly High Momentum Picks - newser.com
Why global investors buy Pulmatrix Inc. (2PU) stockRate Hike & Low Risk Entry Point Tips - newser.com
Will Pulmatrix Inc. (2PU) stock sustain uptrend momentumQuarterly Trade Summary & Precise Swing Trade Alerts - newser.com
Combining machine learning predictions for Pulmatrix Inc.Quarterly Portfolio Review & Risk Controlled Daily Trade Plans - newser.com
Intraday pattern recognizer results for Pulmatrix Inc.July 2025 Retail & Safe Swing Trade Setups - newser.com
Analyzing drawdowns of Pulmatrix Inc. with statistical toolsTrade Volume Summary & Weekly Stock Breakout Alerts - newser.com
What momentum shifts mean for Pulmatrix Inc.Product Launch & Weekly High Conviction Ideas - newser.com
Is Pulmatrix Inc. forming a bottoming baseJuly 2025 EndofMonth & Safe Capital Growth Tips - newser.com
Pulmatrix Inc Azioni (PULM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.96%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):